NMO Spectrum Evaluation (AQP4 with Reflex to MOG), CSF
Test Code
Clinical Significance
NMO Spectrum Evaluation (AQP4 with Reflex to MOG), CSF - NMO (neuromyelitis optica, Devic disease) is an immune- mediated chronic inflammatory disease that predominantly affects the optic nerve and spinal cord and presents with optic neuritis (ON) and myelitis. Limited forms of this disease, such as isolated ON, brainstem encephalitis and longitudinal extensive transverses myelitis (LETM), have been referred to as NMO spectrum disorders (NMOSD). NMO was originally thought to be a variant of multiple sclerosis but is now recognized as a distinct disease. The presence of serum antibodies against aquaporin-4 (AQP4) or myelin oligodendrocyte glycoprotein (MOG-IgG) is associated with NMO and NMOSD.
Test Resources
Test Details
If the Aquaporin 4 Antibody, CSF is negative, then MOG Antibody, CBA will be performed at an additional charge (CPT code: 86362).
If the MOG Antibody, CBA, CSF is positive, then MOG Antibody, Titer, CSF will be performed at an additional charge (CPT code: 86362).
Methodology
Reference Range(s)
| Aquaporin 4 Ab, CBA, CSF | Negative |
| Aquaporin 4 Ab, Titer, CSF | <1:10 Titer |
| MOG Ab, CBA, CSF | Negative |
| MOG Ab, Titer, CSF | <1:2 Titer |
Alternative Name(s)
Preferred Specimen(s)
2 mL CSF collected in a sterile plastic screw-cap vial
Minimum Volume
1 mL
Transport Container
Transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 14 days
- Frozen: 21 days
Reject Criteria
Visible particulate matter
Setup Schedule
Refrigerated: 14 days
Frozen: 21 days